Obesity and Clinical Riskiness Relationship: Therapeutic Management by Dietary Antioxidant Supplementation—a Review

Applied Biochemistry and Biotechnology

Volumn 176, Issue 3, 2015, Pages 647-669

  Hassan, Hanaa A ^a   El Gharib, Nermin E ^a  

^a MANSOURA UNIVERSITY   (Egypt)

Author keywords

Atherosclerosis; Cardiovascular disease; Diabetes; Dietary natural antioxidants; Diseases associated obesity; Herbal medicine; Obesity

Indexed keywords

ANTIOXIDANTS; BLOOD PRESSURE; CARDIOLOGY; DIETARY SUPPLEMENTS; DISEASES; DRUG INTERACTIONS; MEDICAL PROBLEMS; MEDICINE; PLANT EXTRACTS; TISSUE;

ATHEROSCLEROSIS; CARDIO-VASCULAR DISEASE; HERBAL MEDICINES; NATURAL ANTIOXIDANTS; OBESITY;

NUTRITION;

ANTIOXIDANT; CROCUS SATIVUS EXTRACT; CURCUMIN; FENUGREEK EXTRACT; GARLIC EXTRACT; GINGER EXTRACT; GOLDENBERRY EXTRACT; GREEN TEA EXTRACT; SOUR ORANGE EXTRACT; UNCLASSIFIED DRUG; WHITE KIDNEY BEAN EXTRACT;

CALORIC INTAKE; CARDIOVASCULAR DISEASE; CEREBROVASCULAR ACCIDENT; CHERRY; COGNITION; COMORBIDITY; CORONARY ARTERY DISEASE; CROCUS SATIVUS; DIABETES MELLITUS; DIET SUPPLEMENTATION; FENUGREEK; FOOD INTAKE; GARLIC; GINGER; GOLDENBERRY; HEALTH HAZARD; HERBAL MEDICINE; HUMAN; INFLAMMATION; LUNG FUNCTION; MEMORY; MORTALITY; NEOPLASM; OAT; OBESITY; PHASEOLUS VULGARIS; PHYSALIS; PORTULACACEAE; RESPIRATORY TRACT DISEASE; REVIEW; SOUR ORANGE; TEA; ANIMAL; COMPLICATION; DIET THERAPY; DIETARY SUPPLEMENT; METABOLISM; PATHOPHYSIOLOGY; RISK;

ANIMALS; ANTIOXIDANTS; DIETARY SUPPLEMENTS; HUMANS; OBESITY; RISK;

EID: 84937817429     PISSN: 02732289     EISSN: 15590291     Source Type: Journal    
DOI: 10.1007/s12010-015-1602-6     Document Type: Review

References (174)

1. Cheng, M. L., Zhao, S. M., Li, W. Z., Zhang, X., Ge, C. R., Duan, G., & Gao, S. Z. (2010). Anti-adipocyte scFv-Fc antibody suppresses subcutaneous adipose tissue development and affects lipid metabolism in minipigs. Applied Biochemistry and Biotechnology, 162, 687–697.
2. Aronne, L. J., & Segal, K. R. (2002). Adiposity and fat distribution outcome measures: assessment and clinical implications. Obesity Journal, 10, 14–21.
3. Bajari, T. M., Nimpf, J., & Schneider, W. J. (2004). Role of leptin inreproduction. Journal of Current Opinion Lipidology, 15, 315–319.
4. Baskin, D. G., Breininger, J. F., & Schwartz, M. W. (1999). Leptin receptor mRNA identifies a subpopulation of neuropeptide Y neurons activated by fasting in rat hypothalamus. Diabetes Journal, 48, 828–833.
5. Jabeen, A., Khan, U. A., & Lodhi, G. M. (2011). Effects of simvastatin on lipid profile and nerve conduction velocity in obese sprague dawley rats. Journal of Ayub Medical College, 23, 36–39.
6. Bray, G. A. (2004). How do we get fat? An epidemiologic and metabolic approach. Clinical Dermatology, 22, 281–288.
7. Ellacott, K. L., Murphy, J. G., Marks, D. L., & Cone, R. D. (2007). Obesity-induced inflammation in white adipose tissue is attenuated by loss of melanocortin-3 receptor signaling. Journal of Endocrinology, 148, 6186–6194.
8. Bray, G. A. (2002). The underlying basis for obesity: relationship to cancer. Journal of Nutrition, 132, 3451–3455.
9. Morrill, A. C., & Chinn, C. D. (2004). The obesity epidemic in the United States. Journal of Public Health Policy, 25, 353–366.
10. Mobbs, C. V., Moreno, C. L., & Poplawski, M. (2013). Metabolic mystery: aging, obesity, diabetes, and the ventromedial hypothalamus. Endocrinology and Metabolism, 24, 488–494.
11. Must, A., Spadano, J., Coakley, E. H., Field, A. E., Colditz, G., & Dietz, W. H. (1999). The disease burden associated with over-weight and obesity. Journal of American Medical Association, 282, 1523–1529.
12. Gautier, A., Roussel, R., Ducluzeau, P. H., Lange, C., Vol, S., Balkau, B., & Bonnet, F. (2010). Increases in waist circumference and weight as predictors of type 2 diabetes in individuals with impaired fasting glucose: influence of baseline BMI. Diabetes Care, 33, 1850–1852.
13. Colditz, G. A., Willett, W. C., Rotnitzky, A., & Manson, J. E. (1995). Weight gain as a risk factor for clinical diabetes mellitus in women. Annual International Medical, 122, 481–486.
14. Koh-Banerjee, P., Wang, Y., Hu, F. B., Spiegelman, D., Willett, W. C., & Rimm, E. B. (2004). Changes in body weight and body fat distribution as risk factors for clinical diabetes in US men. American Journal of Epidemiology, 159, 1150–1159.
15. Guh, D. P., Zhang, W., Bansback, N., Amarsi, Z., Birmingham, C. L., & Anis, A. H. (2009). The incidence of co-morbidities related to obesity and overweight: a systematic review and meta-analysis. Bio-Med Central and Public Health, 9, 88.
16. Bayturan, O., Tuzcu, E. M., & Lavoie, A. (2010). The metabolic syndrome, its component risk factors, and progression of coronary atherosclerosis. Archives of Internal Medicine, 170, 478–484.
17. Jena, P. K., Singh, S., Prajapati, B., Nareshkumar, G., Mehta, T., & Seshadri, S. (2014). Impact of targeted specific antibiotic delivery for gut microbiota modulation on high-F. Applied Biochemistry and Biotechnology, 172, 3810–3826.
18. Basciano, H., Federico, L., & Adeli, K. (2005). Fructose, insulin resistance, and metabolic dyslipidemia. Nutrition and Metabology, 2, 1–14.
19. Rocha, V. Z., & Libby, P. (2009). Obesity, inflammation, and atherosclerosis. Nature Reviews Cardiology, 6, 399–409.
20. Li, G., Zhang, P., & Wang, J. (2008). The long-term effect of lifestyle interventions to prevent diabetes in the China Da Qing diabetes prevention study: a 20-year follow-up study. Lancet Journal, 371, 1783–1789.
21. Nisha, V. M., Anusree, S. S., Priyanka, A., & Raghu, K. G. (2014). Apigenin and quercetin ameliorate mitochondrial alterations by tunicamycin-induced ER stress in 3 T3-L1 adipocytes. Applied Biochemistry and Biotechnology, 174, 1365–1375.
22. Trayhurn, P., & Beattie, J. H. (2001). Physiological role of adipose tissue: white adipose tissue as an endocrine and secretory organ. Proceedings of the Nutrition Society, 60, 329–339.
23. Boden, G., Duan, X., Homko, C., Molina, E. J., Song, W., Perez, O., Cheung, P., & Merali, S. (2008). Increase in endoplasmic reticulum stress-related proteins and genes in adipose tissue of obese, insulin-resistant individuals. Journal of Diabetes, 57, 2438–2444.
24. Kawasaki, N., Asada, R., Saito, A., Kanemoto, S., & Imaizumi, K. (2012). Obesity-induced endoplasmic reticulum stress causes chronic inflammation in adipose tissue. Scientific Reports, 2, 799.
25. Xu, C., Bailly-Maitre, B., & Reed, J. C. (2005). Endoplasmic reticulum stress: cell life and death decisions. Clinical Investigation, 115, 2656–2664.
26. Bogers, R. P., Bemelmans, W. J., & Hoogenveen, R. T. (2007). Association of overweight with increased risk of coronary heart disease partly independent of blood pressure and cholesterol levels: a meta-analysis of 21 cohort studies including more than 300,000 persons. Archives of Internal Medicine, 167, 1720–1728.
27. Strazzullo, P. D., Elia, L., Cairella, G., Garbagnati, F., Cappuccio, F. P., & Scalfi, L. (2010). Excess body weight and incidence of stroke: meta-analysis of prospective studies with 2 million participants. Journal Stroke, 41, 418–426.
28. McGee, D. L. (2005). Body mass index and mortality: a meta-analysis based on person-level data from twenty-six observational studies. Annual Epidemiology, 15, 87–97.
29. American Institute for Cancer Research (AIC). (2007). World cancer research fund. Food, nutrition, physical activity and the prevention of cancer. Washington: American Institute for Cancer Research.
30. Eliassen, A. H., Colditz, G. A., Rosner, B., Willett, W. C., & Hankinson, S. E. (2006). Adult weight change and risk of postmenopausal breast cancer. Journal of American Medical Association, 296, 193–201.
31. Heilbronn, L. K., & Campbell, L. V. (2008). Adipose tissue macrophages, low grade inflammation and insulin resistance in human obesity. Current Pharmaceutical Design, 14, 1225–1230.
32. Gustafson, B. (2010). Adipose tissue, inflammation and atherosclerosis. Journal of Atherosclerosis Thrombosis, 17, 332–341.
33. Hotamisligil, G. S. (2006). Inflammation and metabolic disorders. Journal of Natural, 444, 860–867.
34. Gesta, S., Tseng, Y. H., & Kahn, C. R. (2007). Developmental origin of fat: tracking obesity to its source. Journal of Cell, 131, 242–256.
35. McClean, K. M., Kee, F., Young, I. S., & Elborn, J. S. (2008). Obesity and the lung: epidemiology. Thorax Journal, 63, 649–654.
36. Beuther, D. A., & Sutherland, E. R. (2007). Overweight, obesity, and incident asthma: a meta-analysis of prospective epidemiologic studies. American Journal of Respiratory and Critical Care Medicine, 175, 661–666.
37. Tuomilehto, H. P., Seppa, J. M., & Partinen, M. M. (2009). Lifestyle intervention with weight reduction: first-line treatment in mild obstructive sleep apnea. American Journal of Respiratory and Critical Care Medicine, 179, 320–327.
38. Nerfeldt, P., Nilsson, B. Y., Mayor, L., Udden, J., & Friberg, D. (2010). A two-year weight reduction program in obese sleep apnea patients. Clinical Sleep Medicine, 6, 479–486.
39. Alzheimer’s Association (2012). Alzheimer’s facts and figures. Alzheimer’s & Dementia. 2010.
40. Beydoun, M. A., Beydoun, H. A., & Wang, Y. (2008). Obesity and central obesity as risk factors for incident dementia and its subtypes: a systematic review and meta-analysis. Obesity Reviews, 9, 204–218.
41. Profenno, L. A., Porsteinsson, A. P., & Faraone, S. V. (2010). Meta-analysis of Alzheimer’s disease risk with obesity, diabetes, and related disorders. Biological Psychiatry, 67, 505–512.
42. Kazemipoor, M., Radzi, J. W. M., Cordell, G. A., & Yaze, I. (2012). Potential of traditional medicinal plants for treating obesity: a review. International Conference on Nutrition and Food Sciences, 39, 1–6.
43. Duthie, G. G., Gardner, P. T., & Kyle, J. A. (2003). Plant polyphenols: are they the new magic bullet? Proceeding Nutrition Society, 62, 599–603.
44. Naik, R. S., Mujumdar, A. M., & Ghaskadbi, S. (2004). Protection of liver cells from ethanol cytotoxicity by curcumin in liver slice culture in vitro. Ethnopharmacology, 95, 31–37.
45. Bengmark, S. (2006). Curcumin, an atoxic antioxidant and natural NF-B, cyclooxygenase-2, lipoxygenases, and inducible nitric oxide synthase inhibitor: a shield against acute and chronic diseases. Journal of Parenter Enteral Nutrition, 30, 45–51.
46. Masuda, T., Hidaka, K., Shinohara, A., Maekawa, T., Takeda, Y., & Yamaguchi, H. (1999). Chemical studies on antioxidant mechanism of curcuminoid: analysis of radical reaction products fromcurcumin. Journal of Agricultural and Food Chemistry, 47, 71–77.
47. Daniel, S., Limson, J. L., Dairam, A., Watkins, G. M., & Daya, S. (2004). Through metal binding, curcumin protects against lead- and cadmium-induced lipid peroxidation in rat brain homogenates and against lead-induced tissue damage in rat brain. Inorganic Biochemistry, 98, 266–275.
48. Kuhad, A., & Chopra, K. (2007). Curcumin attenuates diabetic encephalopathy in rats: behavioral and biochemical evidences. European Journal of Pharmacology, 576, 34–42.
49. Jiang, J., Wang, W., Sun, Y. J., Hu, M., Li, F., & Zhu, D. Y. (2007). Neuroprotective effect of curcumin on focal cerebral ischemic rats by preventing blood–brain barrier damage. European Journal of Pharmacology, 561, 54–62.
50. El-Habibi, E. M., El-Wakf, A. M., & Mogall, A. (2013). Efficacy of curcumin in reducing risk of cardiovascular disease in high fat diet-fed rats. Journal of Bioanalysis and Biomedicine, 5, 66–70.
51. Ejaz, A., Wu, D., Kwan, P., & Meydani, M. (2009). Curcumin inhibits adipogenesis in 3 T3-L1 adipocytes and angiogenesis and obesity in C57/BL mice 1–3. Journal of Nutrition, 139, 919–925.
52. Tirkey, N., Kaur, G., Vij, G., & Chopra, K. (2005). Curcumin, a diferuloylmethane, attenuates cyclosporine induced renal dysfunction and oxidative stress in rat. kidneys. Pharmacology Journal, 5, 15–25.
53. Eybl, V., Kotyzova, D., & Koutensky, J. (2006). Comparative study of natural antioxidants curcumin, resveratrol and melatonin in cadmiuminduced oxidative damage in mice. Toxicology Journal, 225, 150–156.
54. Rajakrishnan, V., Viswanathan, P., Rajasekharan, K. N., & Menon, V. P. (1999). Neuroprotective role of curcumin from Curcuma longa on ethanol-induced brain damage. Journal of Phytotherapy Research, 13, 571–574.
55. Fu, Y., Zheng, S., Lin, J., Ryerse, J., & Chen, A. (2008). Curcumin protects the rat liver from CCl4-caused injury and fibrogenesis by attenuating oxidative stress and suppressing inflammation. Journal of Molecular Pharmacology, 73, 399–409.
56. Jain, S. K., Rains, J., & Jones, K. (2006). Effect of curcumin on protein glycosylation, lipid peroxidation, and oxygen radical generation in human red blood cells exposed to high glucose levels. Free Radical Biology and Medicine, 41, 92–96.
57. Nguyen, K. T., Shaikh, N., Shukla, K. P., Su, S. H., Eberhart, R. C., & Tang, L. (2004). Molecular responses of vascular smooth muscle cells and phagocytes to curcumin-eluting bioresorbable stent materials. Journal of Biomaterials Applications, 25, 5333–5346.
58. Yang, J. Y., Della-Fera, M. A., Nelson-Dooley, C., & Baile, C. (2006). Molecular mechanisms of apoptosis induced by ajoene in 3 T3–L1 adipocytes. Obesity Journal, 14, 388–397.
59. Pendurthi, U. R., & Rao, L. V. (2000). Suppression of transcription factor Egr-1 by curcumin. Thrombosis Research Journal, 97, 179–189.
60. Fan, C., Wo, X., Qian, Y., Yin, J., & Gao, L. (2006). Effect of curcumin on the expression of LDL receptor in mouse macrophages. Journal of Ethnopharmacology, 105, 251–254.
61. Ramirez-Bosca, A., Soler, A., Carrion-Gutierrez, M. A., Pamies-Mira, D., Pardo Zapata, J., Diaz-Alperi, J., Bernd, A., Quintanilla Almagro, E., & Miquel, J. (2000). An hydroalcoholic extract of Curcuma longa lowers the abnormally high values of human-plasma fibrinogen. Mechanisms of Ageing and Development Journal, 114, 207–210.
62. Chen, W. F., Deng, S. L., Zhou, B., Yang, L., & Liu, Z. L. (2006). Curcumin and its analogues as potent inhibitors of low density lipoprotein oxidation: H-atom abstraction from the phenolic groups and possible involvement of the 4-hydroxy-3-methoxyphenyl groups. Free Radical Biology and Medicine, 40, 526–535.
63. El-Wakf, M. A., Hassan, A. H., & Habza, N. M. (2015). Efficacy of fenugreek to ameliorate nitrate-induced diabetes in young and adult male rats. Journal of Cytotechnology, 67, 437–447.
64. Brown, A. L., Lane, J., Holyoak, C., Nicol, B., Mayes, A. E., & Dadd, T. (2011). Health effects of green tea catechins in overweight and obese men: a randomised controlled cross-over trial. British Journal of Nutrition, 7, 1–10.
65. Zheng, J., Yang, B., Huang, T., Yu, Y., Yang, J., & Li, D. (2011). Green tea and black tea consumption and prostate cancer risk: an exploratory meta-analysis of observational studies. Nutrition and Cancer Journal, 63, 663–672.
66. Sun, C. L., Yuan, J. M., Lee, M. J., Yang, C. S., Gao, Y. T., Ross, R. K., & Yu, M. C. (2002). Urinary tea polyphenols in relation to gastric and esophageal cancers: a prospective study of men in Shanghai, China. Carcinogenesis Journal, 23, 1497–1503.
67. Zheng, G., Sayama, K., Okubo, T., Juneja, L. & Oguni, I. (2004). Anti-obesity effects of three major components of green tea, catechins, caffeine and theanine, in mice. in vivo, 18, 55–62.
68. Ahmad, N., Fayes, D. K., Nieminen, A. L., Agarwal, R., & Mukhtar, H. (1997). Green tea constituent epigallocatechin-3-gallate and induction of apoptosis and cell cycle arrest in human carcinoma cells. Journal of National Cancer Institute, 89, 1881–1889.
69. Cao, Y., & Cao, R. (1999). Angiogenesis inhibited by drinking tea. Journal of Nature, 398, 381.
70. Kono, S., Shinchi, K., Wakabayashi, K., Honjo, S., Todoroki, I., Sakurai, Y., Imanishi, K., Nishizawa, H., Ogawa, S., & Katsurada, M. (1996). Relation of green tea consumption to serum lipids and lipoproteins in Japanese men. Journal of Epidemiology, 6, 128–133.
71. Bettuzzi, S., Brausi, M., Rizzi, F., Castagnetti, G., Peracchia, G., & Corti, A. (2006). Chemoprevention of human prostate cancer by oral administration of green tea catechins in volunteers with high-grade prostate intraepithelial neoplasia: a preliminary report from a one-year proof-of-principle study. Journal of Cancer Research, 66, 1234–1240.
72. Kao, Y. H., Hiipakka, R. A., & Liao, S. (2000). Modulation of obesity by a green tea catechin. American Journal of Clinical Nutrition, 72, 1232–1234.
73. Rumpler, W., Seale, J., Clevidence, B., Judd, J., Wiley, E., Yamamoto, S., Komatsu, T., Sawaki, T., Ishikura, Y., & Hosoda, K. (2001). Oolong tea increases metabolic rate and fat oxidation in men. Journal of Nutrition, 131, 2848–2852.
74. Kao, Y. H., Hiipakka, R. A., & Liao, S. (2000). Modulation of endocrine systems and food intake by green tea epigallocatechingallate. Endocrinology Journal, 141, 980–987.
75. Dulloo, A. G., Seydoux, J., Girardier, L., Chantre, P., & Vandermander, J. (2000). Green tea and thermogenesis: interactions between catechin-polyphenols, caffeine and sympathetic activity. International Journal of Obesity, 24, 252–258.
76. Kobayashi, K., Nagato, Y., Aoi, N., Juneja, L. R., Kim, M., Yamamoto, T., & Sugimoto, S. (1998). Effects of L-theanine on the release of brain waves in human volunteers. Nippon Nogeikagaku Kaishi Journal, 72, 153–157.
77. Yokogoshi, H., Kobayashi, M., Mochizuki, M., & Terashima, T. (1998). Effect of theanine, Á glutamylethylamide, on brain monoamines and striatal dopamine release in conscious rats. Neurochemical Research Journal, 23, 667–673.
78. Kakuda, T., Nozawa, A., Unno, T., Okamura, N., & Okai, O. (2000). Inhibiting effects of theanine on caffeine stimulation evaluated by EEG in the rat. Bioscience Biotechnology Biochemistry, 64, 287–293.
79. Peyron, L. (2002). Production of bitter orange neroli and pettigrain oils. In J. Dugo & A. DiGiacomo (Eds.), Citrus: The genus citrus. London & New York: Taylor & Francis.
80. Bent, S., Padula, A., & Nehuaus, J. (2004). Safety and efficacy of citrus aurantium for weight loss. American Journal of Cardiology, 94, 1359–1361.
81. Preuss, H. G., DiFernando, D., Bagchi, M., & Bagchi, D. (2002). Citrus aurantium as a thermogenic, weight-reduction replacement for ephedra: an overview. Journal of Medicine, 33, 247–264.
82. Carpene, C., Galitzky, J., Fontana, E., Atgie, C., Lafontan, M., & Berlan, M. (1999). Selective activation of beta3-adrenoceptors by octopamine: comparative studies in mammalian fat cells. NaunynSchmiedebergs Archives Pharmacology, 359, 310–321.
83. Bui, L. T., Nguyen, D. T., & Ambrose, P. J. (2006). Blood pressure and heart rate effects following a single dose of bitter orange. Annals Pharmacotherapy, 40, 53–57.
84. Stohs, S. J., Preuss, H. G., & Shara, M. (2012). A review of the human hlinical studies involving Citrus aurantium (Bitter Orange) extract and its primary protoalkaloid p-Synephrine. International Journal of Medical Sciences, 9, 527–538.
85. Arias, B. A., & Ramón-Laca, L. (2005). Pharmacological properties of citrus and their ancient and medieval uses in the Mediterranean region. Journal of Ethnopharmacology, 97, 89–95.
86. Slezak, T., Francis, P. S., Anastos, N., & Barnett, N. W. (2007). Determination of synephrine in weight-loss products using high performance liquid chromatography with acidic potassium permanganate chemiluminescence detection. Journal of Analytica Chimica Acta, 593, 98–102.
87. Haaz, S., Fontaine, K. R., Cutter, G., Limdi, N., Perumean-Chaney, S., & Allison, D. B. (2006). Citrus aurantium and synephrine alkaloids in the treatment of overweight and obesity: an update. Obesity Review, 7, 79–88.
88. Stohs, S. J., Preuss, H. G., & Shara, M. A. (2011). A review of the receptor-binding properties of p-synephrine as related to its pharmacological effects. Oxidative Medicine and Cellular Longevity, 2011, 1–9.
89. Carai, M. A., Fantini, N., Loi, B., Colombo, G., Riva, A., & Morazzoni, P. (2009). Potential efficacy of preparations derived from Phaseolus vulgaris in the control of appetite, energy intake, and carbohydrate metabolism. Diabetes Metabolic Syndrome and Obesity, 2, 145–153.
90. Bazzano, L. A., He, J., Ogden, L. G., Loria, C. M., & Whelton, P. K. (2003). Dietary fiber intake and reduced risk of coronary heart disease in US men and women: the national health and nutrition examination survey I epidemiologic follow-up study. Archives of Internal Medicine, 163, 1897–1904.
91. Queiroz, K. S., de Oliveira, A. C., & Helbig, E. (2002). Soaking the common bean in a domestic preparation reduced the contents of raffinose-type oligosaccharides but did not interfere with nutritive value. Journal of Nutritional Science and Vitaminology, 48, 283–289.
92. Barrett, M. L., & Udani, J. K. (2011). A proprietary alpha-amylase inhibitor from white bean (Phaseolus vulgaris): a review of clinical studies on weight loss and glycemic control. Nutritional Journal, 10, 24–29.
93. McIntosh, M., & Miller, C. A. (2001). Diet containing food rich in soluble and insoluble fiber improves glycemic control and reduces hyperlipidemia among patients with type 2 diabetes mellitus. Nutrition Review, 59, 52–55.
94. Gibson, L. & Benson, G. (2002). Origin, history, and uses of oat (Avena sativa) and wheat (Triticum aestivum). Iowa State University. Department of Agronomy.
95. Kurtz, E. S., & Wallo, W. (2007). Colloidal oat meal: history, chemistry and clinical properties. Journal of Drugs Dermatology, 6, 167–170.
96. Vader, L. W., Stepniak, D. T., & Bunnik, E. M. (2003). Characterization of cereal toxicity for celiac disease patients based on protein homology in grains. Gastroenterology Journal, 125, 1105–1113.
97. Tapola, N., Karvonen, H., Niskanen, L., Mikola, M., & Sarkkinen, E. (2005). Glycemic responses of oat bran products in type 2 diabetic patients. Journal of Nutrition Metabolism and Cardiovascular Diseases, 15, 255–261.
98. Hassan, H. A. (2007). Therapeutic effect of oat (Avena sativa L) grains and atorvastatin drug against physiological alterations on lipids metabolism and oxidative stress in cholesterol-fed rats. Egypt Journal of Zoology, 48, 191–207.
99. Queenan, K. M., Stewart, M. L., Smith, K. N., Thomas, W., Fulcher, R. G., & Slavin, J. L. (2007). Concentrated oat beta-glucan, a fermentable fiber, lowers serum cholesterol in hypercholesterolemic adults in a randomized controlled trial. Nutrition Journal, 6, 1–6.
100. Ellegård, L., & Andersson, H. (2007). Oat bran rapidly increases bile acid excretion and bile acid synthesis: an ileostomy study. European Journal of Clinical Nutrition, 61, 938–945.
101. El-Wakf, M. A., Hassan, A. H., El-komy, M. M., & Amr, M. M. (2011). Role of dietary fibers in the management of diabetes induced heart disease in male rats. Journal of American Science, 7, 638–649.
102. Poppitt, S. D. (2007). Soluble fibre oat and barley beta-glucan enriched products: can we predict cholesterol-lowering effects? British Journal of Nutrition, 97, 1049–1050.
103. Arun, M., & Asha, V. V. (2007). Preliminary studies on antihepatotoxic effect of Physalisperuviana Linn. (Solanaceae) against carbon tetrachloride induced acute liver injury in rats. Journal of Ethnopharmacology, 111, 110–114.
104. Wu, S. J., Tsai, J. Y., Chang, S. P., Lin, D. L., Wang, S. S., Huang, S. N., & Ng, L. T. (2006). Supercritical carbon dioxide extract exhibits enhanced antioxidant and anti-inflammatory activities of Physalisperuviana. Journal of Ethnopharmacology, 108, 407–413.
105. Wu, S. J., Ng, L. T., Lin, D. L., Wang, S. S., & Lin, C. C. (2004). Physalis peruviana extract induces apoptosis in human Hep G2 cells through CD95/CD95L system and mitochondrial signalling transduction pathway. Cancer Letters Journal, 215, 199–208.
106. Mayorga, H., Knapp, H., Winterhalter, P., & Duque, C. (2001). Glycosidically bound flavor compounds of cape gooseberry (Physalisperuviana L.). Journal of Agricultural and Food Chemistry, 49, 1904–1908.
107. Gutierrez, M. S., Trinchero, G. D., Cerri, A. M., Vilella, F., & Postharvest, G. O. (2008). Different responses of goldenberry fruit treated at four maturity stages with the ethylene antagonist 1-methylcyclopropene. Journal of Postharvest Biology and Technology, 48, 199–205.
108. Ramadan, M. F., Zayed, R., Abozid, M., & Asker, M. M. S. (2011). Apricot and pumpkin oils reduce plasma cholesterol and triacylglycerol concentrations in rats fed a highfat diet. Grasas Aceites Journal, 62, 443–452.
109. Ramadan, M. F., & Morsel, J. T. (2003). Oil goldenberry (Physalisperviana L.). Journal of Agricultural and Food Chemistry, 51, 969–974.
110. Ramadan, M. F., & Mörsel, J. T. (2009). Oil extractability from enzymatically-treated goldenberry (Physalisperuviana L.) pomace: range of operational variables. International Journal of Food Science Technology, 44, 435–444.
111. Wang, I. K., Lin-Shiau, S. Y., & Lin, J. K. (1999). Induction of apoptosis by apigenin and related flavonoids through cytochrome c release and activation of caspase-9 and caspase-3 in leukaremia HL-60 cells. European Journal of Cancer, 35, 1517–1525.
112. Sgaroba, M. A., & Ramadan, F. M. (2011). Rheological behavior and physiochemical characteristics of goldenberry (Physalis Peruviana) juice as affected by enzymatic treatment. Journal of Food Processing and Preservation, 35, 201–219.
113. Ramadan, M. F., & Mörsel, J. T. (2007). Impact of enzymatic treatment on chemical composition, physicochemical properties and radical scavenging activity of goldenberry (Physalisperuviana L.) juice. Journal of Science Food Agriculture, 87, 452–460.
114. Ramadan, M. F. (2012). Physalisperuvianapomace suppresses high-cholesterol diet-induced hypercholesterolemia in rats. International Journal of Fats and Oils, 63, 411–422.
115. Ferretti, G., Bacchetti, T., Belleggia, A., & Neri, D. (2010). Cherry antioxidants: from farm to table. Molecules Journal, 15, 6993–7005.
116. Martin, K. R., & Burrell, L. (2010). 100% tart cherry juice reduces pro-inflammatory biomarkers in verweight and obese subjects. Journal of Federation American Society Experimental Biology, 24, 15.
117. Seymour, E. M., Singer, A. A., & Kirakosyan, A. (2008). Altered hyperlipidemia, hepatic steatosis, and hepatic peroxisome proliferator activated receptors in rats with intake of tart cherry. Journal of Medicinal Food, 11, 252–259.
118. Coles, K. (2011). The Effects of 100% Tart cherry juice on plasma lipid values and markers of inflammation in overweight and obese subjects by A Thesis Presented in Partial Fulfillment of the Requirements for the Degree Master of Science.
119. Pittler, M. H., & Ernst, E. (2005). Complementary therapies for reducing body weight: a systematic review. International Journal of Obesity, 29, 1030–1038.
120. Abdullaev, F., & Espinosa-Aguirre, J. (2004). Biomedical properties of saffron and its potential use in cancer therapy and chemoprevention trials. Cancer Detection and Prevention, 28, 426–432.
121. Charles, D. J. (2013). Saffron. In antioxidant properties of spices, herbs and other sources (pp. 509–520). New York: Springer.
122. Poma, A., Fontecchio, G., Carlucci, G., & Chichiricco, G. (2012). Anti-inflammatory properties of drugs from saffron crocus. Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry, 11, 37–51.
123. Kamalipour, M., & Akhondzadeh, S. (2011). Cardiovascular effects of saffron: an evidence-based review. Journal Tehran University Heart Center, 6, 59–61.
124. Shirali, S., Zahra, B. S., & Nakhjavani, M. (2012). Effect of crocin on the insulin resistance and lipid profile of streptozotocin-induced diabetic rats. Phytotherapy Research, 27, 1042–1047.
125. Imenshahidi, M., Hosseinzadeh, H., & Javadpour, Y. (2010). Hypotensive effect of aqueous saffron extract (Crocus sativus L.) and its constituents, safranal and crocin, in normotensive and hypertensive rats. Journal of Phytotherapy Research, 24, 990–994.
126. Sheng, L., Qian, Z., Zheng, S., & Xi, L. (2006). Mechanism of hypolipidemic effect of crocin in rats: crocin inhibits pancreatic lipase. European Journal of Pharmacology, 543, 116–122.
127. Mostafa, S., Ebrahiem, M., & Hasan, H. (2011). Studies of effect of useing Saffron, Cyperus, Manuka Honey and their combination on rats suffering from hyperglycemia (pp. 2285–2308). Cairo: Proceedings of the 6th Arab and 3rd International Annual Scientific Conference on Development of Higher Specific Education Programs in Egypt and the Arab World in the Light of Knowledge Era Requirements.
128. Hosseinzadeh, H., & Noraei, N. B. (2009). Anxiolytic and hypnotic effect of Crocus sativus aqueous extract and its constituents, crocin and safranal, in mice. Journal of Phytotherapy Research, 23, 768–774.
129. Gout, B., Bourgesb, C., & Paineau-Dubreuilb, S. (2010). Satiereal, a Crocus sativus L extract, reduces snacking and increases satiety in a randomized placebo-controlled study of mildly overweight, healthy women. Journal of Nutrition Research, 30, 305–313.
130. García-Lafuente, A., Guillamón, E., Villares, A., Rostagno, M. A., & Martínez, J. A. (2009). Flavonoids as anti-inflammatory agents: implications in cancer and cardiovascular disease. Journal of Inflammation Research, 8, 537–552.
131. Terra, X., Montagut, G., Bustos, M., Llopiz, N., Ardèvol, A., Bladé, C., Fernández-Larrea, J., Pujadas, G., Salvadó, J., & Arola, L. (2009). Grape-seed procyanidins prevent low-grade inflammation by modulating cytokine expression in rats fed a high-fat diet. Journal of Nutrition Biochemical, 20, 210–218.
132. Slanc, P., Doljak, B., Kreft, S., Lunder, M., Janeš, D., & Štrukelj, B. (2009). Screening of selected food and medicinal plant extracts for pancreatic lipase inhibition. Journal of Phytotherapy Research, 23, 874–877.
133. Mashmoul, M., Azlan, A., Khaza, H., Yusof, B. N., & Noor, S. M. (2013). Saffron: a natural potent antioxidant as a promising anti-obesity drug. Antioxidants Journal, 2, 293–308.
134. Tiengburanatam, N., Boonmee, A., Sangvanich, P., & Karnchanatat, A. (2010). A novel α-glucosidase inhibitor protein from the rhizomes of zingiber ottensii valeton. Applied Biochemistry and Biotechnology, 162, 1938–1951.
135. Nicollr, R., & Henein, M. (2009). Ginger (Zingiberofficinales Roscoe): a hot remedy for cardiovascular disease. International Journal of Cardiology, 131, 408–409.
136. Ali, A., & Fahmy, G. (2009). Effects of water extracts of thyme (Thymus vulgaris) and ginger (Zingiberofficinale Roscoe) on alcohol abuse. Journal of Food Chemical Toxicology, 47, 1945–1949.
137. Mahmoud, R. H., & Elnour, W. A. (2013). Comparative evaluation of the efficacy of ginger and orlistat on obesity management, pancreatic lipase and liver peroxisomal catalase enzyme in male albino rats. Medical and Pharmacological Science, 17, 75–83.
138. Kadnur, S., & Goyal, R. (2005). Beneficial effects of Zingiberofficinales Roscoe on fructose induced hyperlipidemia and hyperinsulinemia in rats. Indian Journal of Experimental Biology, 43, 1161–1164.
139. Gerald, B., Badreldin, H., Musbah, O., & Abderrahim, N. (2008). Some phytochemical, pharmacological and toxicological properties of ginger (Zingiberoffcinale roscoe): a review of recent research. Journal of Food and Chemical Toxicology, 46, 409–420.
140. Hassan, H. A., & El-Gendy, A. M. (2003). Evaluation of silymarin and / or ginger effect on induced hepatotoxicity by carbon tetrachloride in male albino rats. Egyptian Journal of Hospital Medicine, 12, 101–112.
141. Shirani, G., & Ganesharanee, R. (2009). Extruded products with fenugreek (Trigonella foenum graecium), chickpea and rice: physical properties, sensory acceptability and glycaemic index. Journal of Food Engineering, 90, 44–52.
142. Moosa, A. M., Rashid, M. U., Asadi, A. Z. S., Ara, N., Uddin, M. M., & Ferdaus, A. (2006). Hypolipidemic effects of fenugreek seed powder. Bangladesh Journal of Pharmacology, 1, 64–67.
143. Renuka, C., Ramesh, N., & Saravanan, K. (2009). Evaluation of the antidiabetic effect of Trigonellafoenumgraecum seed powder on alloxan induced diabetic albino rats. International Journal of Pharmaceutical Technology Research, 1, 1580–1584.
144. Basch, E., Ulbricht, C., Kuo, G., Szapary, P., & Smith, M. (2003). Therapeutic applications of fenugreek. Alternative Medicine Review, 8, 20–27.
145. Yoshikawa, M., Murakami, T., & Komatsu, H. (1997). Medicinal food stuffs. IV. Fenugreek seed. (1): structures of trigoneosidesIa, Ib, IIa, IIb, IIIa and IIIb, new furostanolsaponins from the seeds of Indian Trigonella foenumgraecum L. Journal of Chemical and Pharmaceutical Bulletin, 45, 81–87.
146. Abd-El Mawla, A. M. A., & Osman, H. E. H. (2011). Elicitation of trigonelline and 4 -hydroxy-isoleucine with hypoglycemic activity in cell suspension cultures of Trigonella foenumgraecum L. The Open Conference Proceedings Journal, 2, 80–87.
147. Eidi, A., Eidi, M., & Sokhteh, M. (2007). Effect of fenugreek (Trigonellafoenum graecum L) seeds on serum parameters in normal and streptozotocin-induced diabetic rats. Journal of Nutrition Research, 27, 728–733.
148. Raju, J., Gupta, D., Rao, A. R., Yadava, P. K., & Baquer, N. Z. (2001). Trigonellafoenum-graecum (fenugreek) seed powder improves glucose homeostasis in alloxan diabetic rat tissues by reversing the altered glycolytic, gluconeogenic and lipogenic enzymes. Journal of Molecular and Cellular Biochemistry, 224, 45–51.
149. Buyken, A. E., Toeller, M., Heitkamp, G., Vitelli, F., Stehle, P., Scherbaum, W. A., & Fuller, J. H. (1999). IDDM complications study group: relation of fiber intake to HbA1c and the prevalence of severe ketoacidosis and severehypoglycemia. Diabetologia Journal, 41, 882–890.
150. Lee, M., Kim, I., Kim, C., & Kim, Y. (2011). Reduction of body weight by dietary garlic is associated with an increase in uncoupling protein mRNA expression and activation of AMP-activated protein kinase in diet-induced obese mice. Journal of Nutrition, 141, 1947–1953.
151. Yeh, Y. Y., & Liu, L. (2001). Cholesterol-lowering effect of garlic extracts and organosulfur compounds: human and animal studies. Journal of Nutrition, 131, 989–993.
152. Jalal, R., Bagheri, S. M., Moghimi, A., & Rasuli, M. B. (2007). Hypoglycemic effect of aqueous shallot and garlic extracts in rats with fructose-induced insulin resistance. Journal of Clinical Biochemistry and Nutrition, 41, 218–223.
153. Sobenin, I. A., Andrianova, I. V., Fomchenkov, I. V., Gorchakova, T. V., & Orekhov, A. N. (2009). Time-released garlic powder tablets lower systolic and diastolic blood pressure in men with mild and moderate arterial hypertension. Journal of Hypertension Research, 32, 433–437.
154. Milner, J. A. (2001). A historical perspective on garlic and cancer. Journal of Nutrition, 131, 1027–1031.
155. Hassan, H. A., El-Agmy, S. M., Gaur, R., Fernando, L. A., Raj, H. G., & Ouhtit, A. (2009). In vivo evidence of hepato-and-reno-protective effect of garlic oil against sodium nitrite-induced oxidative stress. International Journal of Biology Science, 5, 249–255.
156. Jisawa, H., Suma, K., Origuchi, K., Kumagai, H., Seki, T., & Ariga, T. (2008). Biological and chemical stability of garlic-derived allicin. Journal of Agricultural and Food Chemistry, 56, 4229–4235.
157. Han, C. Y., Ki, S. H., Kim, Y. W., Noh, K., Lee, Y., Kang, B., Ryu, J. H., Jeon, R., Kim, E. H., & Hwang, S. J. (2011). Ajoene, a stable garlic by-product, inhibits high fat diet-induced hepatic steatosis and oxidative injury through LKB1-dependent AMPK activation. Antioxidants & Redox Signaling Journal, 14, 187–202.
158. Keophiphath, M., Priem, F., Jacquemond-Collet, I., Clément, K., & Lacasa, D. (2009). 1,2-Vinyldithiin from garlic inhibits differentiation and inflammation of human preadipocytes. Journal of Nutrition, 139, 2055–2060.
159. Palaniswamy, U. R., McAvoy, R. J., & Bible, B. B. (2001). Stage of harvest and polyunsaturated essential fatty acid concentrations in purslane (Portulaca oleraceae) leaves. Journal of Agricultural and Food Chemistry, 49, 3490–3493.
160. Mohammadi, A., & Oshaghi, E. A. (2014). Effect of garlic on lipid profile and expression of LXR alpha in intestine and liver of hypercholesterolemic mice. Journal of Diabetes & Metabolic Disorders, 13, 20.
161. Kwon, M. J., Song, Y. S., Choi, M. S., Park, S. J., Jeong, K. S., & Song, Y. O. (2003). Cholesteryl ester transfer protein activity and atherogenic parameters in rabbits supplemented with cholesterol and garlic powder. Life Science Journal, 72, 2953–2964.
162. Lin, M. C., Wang, E. J., Lee, C., Chin, K. T., Liu, D., Chiu, J. F., & Kung, H. F. (2002). Garlic inhibits microsomal triglyceride transfer protein gene expression in human liver and intestinal cell lines and in rat intestine. Journal of Nutrition, 132, 1165–1168.
163. Chan, K., Islam, M. W., Kamil, M., Radakrishnan, R., Zakaria, M. N., Habibullah, M., & Attas, A. (2000). The analgesic and anti-inflammatory effects of portulaca oleracea L Subsp. Sativa (Haw.) Celak. Journal of Ethnopharmacology, 73, 445–451.
164. Simopoulos, A. P., Norman, A. H., Gillaspy, E. J., & Duke, A. J. (1992). Common purslane: a source of omega-3-fatty acids and antioxidants. American Journal of College Nutrition, 11, 374–382.
165. Hussein, A. M. (2010). Purslane extract effects on obesity-induced diabetic rats fed a high-fat diet. Malaysian Journal of Nutrition, 16, 419–429.
166. El-Gendy, A. M., & Hassan, H. A. (2005). The modulatory role of purslane (Portulaca oleraceae) on age-linked changes in old male rats. Egyptian Journal of Biomedical Science, 18, 255–268.
167. Barakat, L. A. A., & Mahmoud, R. H. (2011). The antiatherogenic, renal protective and immunomodulatory effects of purslane, pumpkin and flax seeds on hypercholesterolemic rats. North American Journal of Medical Sciences, 3, 411–417.
168. Romero, A., West, K., Zern, T., & Fernandez, M. (2002). The seeds from plantago ovate lower plasma lipids by altering hepatic and bile acid metabolism in Guinea pigs. Journal of Nutrition, 132, 1194–1198.
169. Venkateson, N., Devaraj, S., & Devaraj, H. (2003). Increased binding of LDL and VLDL to apo B, E receptors of hepatic plasma membrane of rats treated with fibernat. European Journal of Nutrition, 42, 262–271.
170. Daniel, M. (2006). Science publishers, Enfield, NH;. Medicinal Plants: Chemistry and Properties; p. 184.
171. Isin, Y., Ismail, T., Askim, H., & Tijen, D. (2007). Salinity tolerance of (Portulaca oleracea L.) is achieved by enhanced antioxidative system, lower level of lipid peroxidation and proline accumulation. Journal of Environmental and Experimental Botany, 61, 49–57.
172. Movahedian, A., Ghannadi, A., & Vashirnia, M. (2007). Hypocholesterolemic effects of purslane extract on serum lipids in rabbits fed with high cholesterol levels. International Journal of Pharmacology, 3, 285–289.
173. Wurochekke, A., Anthony, A., & Obidah, W. (2008). Biochemical effects on the liver and kidney of rats administered aqueous stem bark extract of Xemenia Americana. African Journal of Biotechnology, 7, 2777–2780.
174. Shehata, M. S. M., & Soltan, S. A. (2012). The effects of purslane and celery on hypercholesterolemic mice. Journal of World Dairy Food Sciences, 7, 212–221.